Citation: Robert Cote, Laura Lynn Eggink, J. Kenneth Hoober. CLEC receptors, endocytosis and calcium signaling[J]. AIMS Allergy and Immunology, 2017, 1(4): 207-231. doi: 10.3934/Allergy.2017.4.207
[1] | Jindan Zhang, Urszula Ogiela, David Taniar, Nadia Nedjah . Improved cloud storage auditing scheme with deduplication. Mathematical Biosciences and Engineering, 2023, 20(5): 7905-7921. doi: 10.3934/mbe.2023342 |
[2] | Yuanfei Tu, Jing Wang, Geng Yang, Ben Liu . An efficient attribute-based access control system with break-glass capability for cloud-assisted industrial control system. Mathematical Biosciences and Engineering, 2021, 18(4): 3559-3577. doi: 10.3934/mbe.2021179 |
[3] | Fawza A. Al-Zumia, Yuan Tian, Mznah Al-Rodhaan . A novel fault-tolerant privacy-preserving cloud-based data aggregation scheme for lightweight health data. Mathematical Biosciences and Engineering, 2021, 18(6): 7539-7560. doi: 10.3934/mbe.2021373 |
[4] | Dengzhi Liu, Zhimin Li, Chen Wang, Yongjun Ren . Enabling secure mutual authentication and storage checking in cloud-assisted IoT. Mathematical Biosciences and Engineering, 2022, 19(11): 11034-11046. doi: 10.3934/mbe.2022514 |
[5] | Xiao-Dong Yang, Ze-Fan Liao, Bin Shu, Ai-Jia Chen . Blockchain-based multi-authority revocable data sharing scheme in smart grid. Mathematical Biosciences and Engineering, 2023, 20(7): 11957-11977. doi: 10.3934/mbe.2023531 |
[6] | Yifeng Yin, Zhaobo Wang, Wanyi Zhou, Yong Gan, Yanhua Zhang . Group key agreement protocol for edge computing in industrial internet. Mathematical Biosciences and Engineering, 2022, 19(12): 12730-12743. doi: 10.3934/mbe.2022594 |
[7] | Yongjun Ren, Yan Leng, Yaping Cheng, Jin Wang . Secure data storage based on blockchain and coding in edge computing. Mathematical Biosciences and Engineering, 2019, 16(4): 1874-1892. doi: 10.3934/mbe.2019091 |
[8] | Xiaodong Yang, Ruixia Liu, Bin Shu, Ningning Ren, Wenjia Wang . A heterogeneous signcryption scheme for smart grid with trusted multi-ciphertext equality test. Mathematical Biosciences and Engineering, 2023, 20(11): 20295-20316. doi: 10.3934/mbe.2023898 |
[9] | Taniya Mukherjee, Isha Sangal, Biswajit Sarkar, Qais Ahmed Almaamari . Logistic models to minimize the material handling cost within a cross-dock. Mathematical Biosciences and Engineering, 2023, 20(2): 3099-3119. doi: 10.3934/mbe.2023146 |
[10] | Lihong Guo, Jian Wang, Haitao Wu, Najla Al-Nabhan . XML security protection scheme based on Kerberos authentication and polynomials authorization. Mathematical Biosciences and Engineering, 2020, 17(5): 4609-4630. doi: 10.3934/mbe.2020254 |
BECCS | bioenergy carbon capture and sequestration |
CCS | carbon capture and sequestration |
CO2 | carbon dioxide |
CO2-eq | carbon dioxide equivalent |
EJ exajoule = 1018 joule | |
EROEI | energy return on energy invested |
FAO | Food and Agriculture Organisation |
GHG | greenhouse gas |
GJ gigajoule = 109 joule | |
Gt gigatonne = 109 tonne | |
HANPP | human appropriation of Net Primary Production |
IPCC | Intergovernmental Panel on Climate Change |
MJ megajoule = 106 joule | |
NPP | Net Primary Production |
WEF | World Economic Forum |
Humans have long used biomass for three broad purposes: for growing food for humans and fodder for farm animals; for energy; and for materials used in construction, implements, clothing, bedding and other uses. Food has always been exclusively produced from biomass, although it is possible to produce carbohydrates artificially from hydrocarbons—and some food additives are today artificially produced. Further, diets vary greatly from country to country and over time. Traditionally, selection of both energy sources and materials was very simple: use the fuel or material that was cheapest and locally available.
For fuel, this nearly always meant biomass in some form or other: as late as 1800 with the industrial revolution well underway, global fossil fuel consumption was probably still under 10 million tonnes [1]. Even today, biomass is the preferred fuel in very poor households because of its low cost and local availability. In the form of fuel wood, as much as 50 EJ (EJ = exajoule = 1018 J) is consumed annually in low-income countries. Modern forms of bioenergy—liquid fuels such as ethanol, together with electricity and combined heat and power systems—only account for about 7 EJ [2]. Today, most of the world's primary energy consumption is still derived from fossil fuels—over 81% in 2014 [3].
International freight transport has made available a far wider range of fuels, particularly fossil and nuclear fuels, to most countries and regions. For example, over 64% of all petroleum used crossed national borders in 2015 [2]. However, such heavy reliance on imported fuels has now led to increasing concerns about energy security, so that an important argument made for the corn ethanol industry in the US is that it reduces dependence on oil from the Middle East. Supporters can also argue that it provides industry and employment in rural areas. A further justification for the ethanol program in the US is that it reduces air pollution emissions, a continuing concern in large urban areas. But in addition to availability, cost, energy security and regional employment considerations, two further considerations are vitally important: the challenges of global fossil fuel energy depletion and global climate change. A complication, of course, is that these various criteria can sometimes be in conflict with each other. Using food crops for bioenergy may well improve US rural prosperity and equity, but risk food security in food importing nations; food security is even more important than energy security.
Biomass-based materials have never experienced the total monopoly enjoyed by biomass-based food, or near-monopoly until 150-200 years ago for energy. Earth, stone and kiln-fired bricks and pottery have always had a major role as construction materials and food utensils, with small amounts of metals playing a minor role. These three broad uses for biomass are not mutually exclusive. Biomass construction materials can be also burnt for fuel after their useful lives. Similarly, spoiled food and used cooking oil can be used for energy, as can methane from sewage works, or from animal wastes.
The remainder of this review is organized as follows. Section 2 discusses human appropriation of Net Primary Production (HANPP), and concludes that if HANPP is raised much beyond about 45%, the absolute amount of NPP available to humanity will likely fall. This value thus sets an upper limit on all human uses of biomass. Section 3 looks at official projections of global food needs, and concludes that increasing quantities of both food and agricultural land will be needed to supply a growing world population. In Section 4, we show that although biomaterials are rapidly losing market share, they can usually enable substantialreductions in greenhouse gas (GHG) emissions if substituted for more energy-intensive materials such as steel or concrete. In Section 5, the role of bioenergy is then discussed. First, we discuss the energy return for biomass: only those bioenergy sources which give net energy can be considered part of global potential. Second, we review published estimates of its global potential, and stress their wide range. Section 6 discusses in turn the various possibilities for using biomass to maximise GHG emission reductions. Finally, Section 7 synthesises the findings of the earlier sections, and points to the need for a systems, "industrial ecology", approach to all human uses of biomass, in order to maximize its carbon reduction potential.
The maximum global limit for all human biomass use, whether for food, forage, energy, or materials, is ultimately fixed by the net primary production (NPP) of Earth's terrestrial ecosystems, defined as the gross annual fixation of living plant matter, minus respiration. Much of this annual production is already used by humans. Foley et al. [4] define this human appropriation of NPP (HANPP), as follows: "the share of global biological productivity that is used, managed, or coopted by human actions." The multiple uses of biomass, and the fact that HANPP is already a large—albeit contested—fraction of NPP (estimates vary from 0.10 to 0.55 [5], depending on what items are included), raises several questions which must be resolved if the global climate mitigation benefits of biomass are to be properly assessed. These questions include:
· How much can the overall HANPP fraction be increased before the absolute global total (in tonnes dry biomass) begins to fall?
· Can NPP itself be increased by humans?
Krausmann et al. [6] calculated that the HANPP, as a fraction of NPP, has doubled over the 20th century. Can humanity continue to increase its share of what Running [7] has found to be a roughly constant value of NPP of 53.6 billion tonnes per year in recentdecades? However, according to Schramski et al. [8], terrestrial NPP has been reduced by 45% over the past two millennia, and in energy terms, is now about 2000 EJ. Kleidon [5] has argued that we cannot significantly raise HANPP. His estimate of present-day HANPP was 40%. Using a vegetation-climate system model, he found that when HANPP reached 45%, the absolute value of HANPP as measured by, for example, grams carbon/m2/day, peaked and then fell for higher percentages of HANPP [9]. This peak occurred mainly because the simulated reduction in precipitation in many regions caused a fall in NPP in water-limited regions, and thus an overall fall in global terrestrial NPP.
Running [7] has likewise argued that total human use of biomass provides a "measurable planetary boundary for the biosphere". He estimated that current HANPP, which he put at roughly a third of NPP, can only rise to a maximum of around 47%. The 53% of NPP which he regarded as "non-harvestable" not only includes plant growth "critical for ecosystem services and biodiversity" but also plant roots, and "wilderness areas where no transportation exists for harvesting." In summary, both Kleidon and Running argue that HANPP can only increase by a small fraction before it runs into limits. Their two estimates for maximum HANPP are close: 45% and 47%, which correspond to 900 EJ and 940 EJ respectively (or roughly 50-52 Gt biomass assuming a lower heating value of 18 GJ/tonne [10]). These values are for all human uses of biomass, and thus represent upper limits on combined biomass use.
This conclusion is supported by the findings discussed above. The rise of human population from perhaps 200 million two millennia ago to 7.3 billion in 2016 has been accompanied by both large rises in HANPP (with a doubling over the past century [6]) together with a large fall in absolute NPP [8]. It is possible that humans could increase global NPP, but is unlikely, given the adverse effects of on-going climate change and pollution, water shortages in some regions, and possible limits on global phosphorus availability [11]. Overcoming these difficulties, if possible, would require large quantities of energy-intensive inputs, so that increased biomass production would be at the expense of lower net energy and lower GHG reductions.
Compared with other sources for energy or materials, it is very easy to "overshoot" on biomass use at all levels, local, regional and global. With wind energy, for example, a natural production limit occurs when the only sites left for accessible wind have low average wind speeds, so that the energy return on energy invested (EROEI) will be very low, and costs per kWh produced very high. In contrast, all dry biomass of a given type has similar calorific content (although for grasses it is lower than for woody biomass). But some biomass should not be used (e.g. some agricultural wastes) because it will lower soil carbon, or increase soil erosion. In such cases both agricultural production—and with it non-harvested residues—will fall. In terms of the above discussion, it is possible for HANPP to exceed its (sustainable) maximum value—at least for a while.
Many bioenergy researchers [12,13,14] explicitly employ a "food first"policy, meaning that the global requirements for food, both now and in the future, should be satisfied first before any bioenergy plantations are contemplated. There are good ethical reasons for explicitly safeguarding food supplies. Searchinger et al. [15] bluntly concluded that: "Our analysis of the three major models used to set government policies in the United States and Europe suggests that ethanol policies in effect are relying on decreases in food consumption to generate GHG savings." Hein and Leemans [11] have even claimed that using food-based crops is threatening future global food supplies by depleting the limited supplies of global phosphorus. However, while a "food first" policy could be considered an ethical imperative, this does not mean that either the existing nutritional mix, or medium-term trends as shown in the Food and Agriculture Organization (FAO) projections [16] in Table 1, should be seen as definitive.
The FAO project that world grain, milk and meat production will all rise from the 2011/13 period out to year 2023 (see Table 1). Grains for animal feed and for biofuels are expected to show higher growth than grain for food. The FAO also project continued strong growth for milk and meat production (Table 1) especially in developing countries. Elsewhere, the FAO have estimated that globally, 3009 million tonnes (Mt) of grain and 455 Mt of meat production will be needed by 2050, given continuation of present trends [17].
The land area for grain is only expected to increase marginally—most of the growth in production will result from anticipated higher yields (Table 1). Nevertheless, these yield gains are far smaller than those projected by Smeets et al. [12], gains which wouldgreatly raise the non-food potential for biomass. Nevertheless, Burnley et al. [18] have argued that historically, "the net effect of higher yields has avoided emissions of up to 161 gigatons of carbon (GtC) (590 GtCO2-e) since 1961."
Food commodity | 2011/131 | 20231 | % increase |
Grains (Mt) | 2391 | 2753 | 15.2 |
Animal feed | 819 | 976 | 19.2 |
Biofuels | 145 | 183 | 25.5 |
Food & other | 1427 | 1594 | 11.7 |
Grain area (Mha) | 716 | 736 | 2.8 |
Yield (t/ha) | 3.34 | 3.74 | 12.0 |
Milk (Mt) | 749 | 928 | 24.0 |
Meat (kg/capita) | 33.8 | 36.2 | 7.1 |
1crop years. Source: [16]. |
Different foodstuffs vary greatly in their food energy return per unit of energy invested (and consequently in their CO2-equivalent (CO2-eq) cost per kilojoule of food energy), and also in the land required per kilojoule of food energy. Acker et al. [19] have shown that in Arizona, USA, the energy inputs can often be more than 100 times the energy value of the foodstuffs grown, although many foods, like lettuce, are not eaten for their energy food value. But even for potatoes, where food energy is important, the ratio was still over 29. Over half the energy input for all foods combined was for irrigation and chemicals (fertilizers, pesticides). Such energy analyses illustrate two important points about net energy for foodstuffs. First, that food production is an energy sink, which we tolerate because we can't do without food—there are no substitutes. Second, the energy return (and corresponding carbon emissions) vary greatly between foodstuffs, being especially high for meat and dairy products [20].
Several researchers have examined the effect that the world population moving to a more vegetarian diet would have on the availability of bioenergy [13,21,22]. In effect, while still giving priority to food production, this approach seeks to improve the efficiency of food provision. There are thus two approaches to reducing the land needed for food agriculture: agricultural intensification and dietary change, although the energy and climate change implications of these two approaches are very different. Intensification implies a non-linear increase in inputs of energy-intensive irrigation, fertilizers and pesticides, and N2O emissions [23,24,25], whereas with dietary change, land and inputs would be reduced roughly in proportion to reduced total output.
We have shown that even with a "food first"policy, there is still some scope for reducing food's "ecological footprint" by dietary shifts. As we discuss below, natural, biomass-based fibres compete with synthetics, and a variety of non-biomass construction and packaging materials compete with biomass-based ones. (Curiously, although a vast amount has been written on the interaction between food production and bioenergy, few papers have dealt in a systematic way with the similar tradeoffs between bioenergy and biomaterials, but see, for example, [26,27,28]). Given this capacity for substitution, materials selection should be guided by criteria other than monetary cost, including energy and CO2-eq minimisation for a given application, such as a new building. This section looks at the general effects of possible increases in biomaterials use on bioenergy potential.
Carmichael [29] has reported that synthetic fibre production in 2014 was 55.2 million tonnes, more than double natural fibres like wool and cotton at 25.6 million tonnes. Overall global plastics production, of which artificial fibres are a sub-set, was 311 million tonnes in 2014 [30]. The steady growth of plastics for consumer products, construction and packaging materials, and synthetic fibres, suggests the possibilities for substitution between biomass-based materials and plastics, largely made from fossil fuels. The World Economic Forum [30] has even promoted the manufacture of plastics from wood products, instead of from fossil fuels.
Table 2 shows the growth in global production of materials—kiln-fired bricks, steel, cement, aluminium and plastics—which compete with wood or wood products in areas such as construction, packaging and textiles. As can be seen, competitor materials have all roughly doubled or even tripled in production over the period 1990-2014, whereas non-fuel wood production has barely grown. Concrete (where sand and crushed rock aggregate together typically have a mass 5-6 times the cement component) today dominates construction materials by mass. Clearly, wood is losing market share in the construction materials sector, just as bioenergy has lost a small share of the energy sector. Yet it has been argued [31,32] that increasing use of timber products can reduce overall GHG emissions (and energy use) in construction, because of the carbon intensity of alternative products. For European conditions, Bribián et al. [32] have calculated the emission factors for sawn softwood used in construction and various other construction materials, shown in Table 3. Intensity has been expressed on both a mass and volume basis.
Material | kg CO2-eq/kg | kg CO2-eq/m3 |
Sawn softwood | 0.30 | 180 |
Concrete | 0.14 | 325 |
Reinforced concrete | 0.18 | 455 |
Steel (reinforcing) | 1.53 | 12,055 |
Aluminium | 8.57 | 23,140 |
Plastics (PVC) | 4.27 | 5975 |
Source: [32] |
Gustavsson and Sathre [31] have highlighted the numerous difficulties in attempting to evaluate whether substituting wood products for other materials results in net CO2-eq emission savings. The main one is that comparisons cannot be made on a simple material mass basis (as in the building materials emission factors given above), since the cladding for a timber house, for example, will have a far lower mass than for a brick one. Another problem is the estimation of carbon storage duration for biomass products, which will be verydifferent for heavy construction timber compared with packaging. Gustavsson and Joelsson [38] analysed the production energy costs of a number of comparable residential buildings in Sweden. Of interest here is the energy comparison of two four-storey residential buildings, one concrete-framed, the other wood-framed. Overall, the wood-framed building required 2.33 GJ/m2 of floor area primary energy, compared with 2.79 GJ/m2 for the concrete framed one, even though the frame constituted only a minor share of total production energy costs.
Timber can also reduce carbon emissions. In an earlier analysis, Gustavsson et al. [39] calculated net carbon emissions for two "functionally equivalent"buildings, one timber-, one concrete-framed. In their carbon accounting they included: "emissions due to fossil fuel use in the production of building materials; the replacement of fossil fuels by biomass residues from logging, wood processing, construction and demolition; carbon stock changes in forests and buildings; and cement process reactions." They showed that wood framing resulted in net reductions of 30 - 130 kg C per m2 of floor area, the exact value depending, among other factors, on the fuel used for electricity production. Importantly, they concluded that: "The carbon mitigation efficiency, expressed in terms of biomass used per unit of reduced carbon emission, is considerably better if the wood is used to replace concrete building material than if the wood is used directly as biofuel." Wood's superiority in energy costs suggests that it will also reduce carbon emissions under a range of electricity feedstocks.
What if wood had kept its 1990 market share for materials? In 1990, wood accounted for 44.5% of the mass of materials listed in Table 3 (bricks were excluded, since no 1990 figure was available). By, 2014, the proportion had fallen to 22.8%, about half its 1990 value. If wood had merely maintained its 1990 share, an extra 1900 Mt of wood would have been used—if available. This rough calculation shows its importance: at a lower heating value of around 18 GJ per tonne (GJ = gigajoules = 109 joules) [10], 1900 Mt corresponds to about 34.2 EJ of primary energy—greater than lower-end estimates of global bioenergy potential. Further, if wood's share in the decades before 1990 was used instead as the basis for calculation, the energy value would be much higher than 34.2 EJ. Already, a wood construction revival is underway, an example being an 18-storey dormitory block under construction in Vancouver [40].
So how to decide between bio-materials and bioenergy? We address this question after looking at the published literature on bioenergy potential.
Bioenergy is very different from other renewable energy (RE) sources in that it is the only RE that relies on combustion to release its (chemical) energy, which makes it similar to fossil fuels. It can thus be co-fired with coal in thermal power stations. Also, like fossil fuels, it can be stored and used later, overcoming the intermittency problems facing its main future RE competitors, solar and wind energy. Because of these advantages, many researchers have placed great hopes in bioenergy to both replace fossil fuels and to play a major role in mitigating climate change [12,41,42]. The Intergovernmental Panel on Climate Change (IPCC) in their latest report [43], likewise envisaged such a role for biomass. Nevertheless, IEA statistics [3] show that although all energy supplied globally from "biofuels and waste supplies" more than doubled from 27 EJ in 1973 to 59 EJ in 2014, its share of global primary energy fell slightly from 10.5% to 10.3% over the same period.
An obvious selection criterion for all energy sources, which has always been implicit, is that an energy source has to deliver net energy: the energy output has to be greater than the energy inputs needed to produce that energy and deliver it to the point of use. That is, the EROEI must at least exceed unity, and ideally should be much greater [44]. The relevant inputs for bioenergy plantations would include the energy costs of seed development, land preparation, planting, fertilizers and herbicides, irrigation and farm equipment for growing the biomass. Harvesting, bioenergy transport, drying and processing of the crop all entail additional energy inputs. It is not clear what fraction of the technical bioenergy potential estimates discussed in Section 5.2 would pass this net energy test. It is also possible that some bioenergy sources could deliver net energy, but fail the second hurdle: the need to deliver GHG reductions.
The only exceptions to the need for positive net energy are for new energy sources. Possible novel sources of electricity, like fusion energy, or new types of PV cell, can afford to be an energy sink while under development, in the hope that future technology developments will lower the input energy requirements and allow the energy source to produce net energy. Also, if the energy is upgraded to a more useful form, such as with converting biomass to electricity, output energy can be less than input energy. For food and biomaterials, matters are more complex. As we have shown, food production is an energy sink, although the energy subsidy per kilojoule of food varies greatly from crop to crop. Similarly, materials are not produced for energy, so an EROEI value is not relevant; nevertheless, it is still important to try to minimize their energy inputs and resultant GHG emissions. But unlike food, many biomaterials can be substituted for competing, more-GHG intensive materials, as discussed in Section 4.
Early analyses of energy return for biomass crops often produced high estimates, although with considerable variation. In two studies of short rotation tree crops in northern Europe, EROEI values of 14.4 and 64.8 were calculated, even when yields were similar. The higher value study, however, excluded both fertilizer and harvesting/chipping costs from energy inputs. In neither case was irrigation required, which can have high energy costs [10]. Gasol et al. [45] found even higher EROEI values—an EROEI value of 88 for direct energy stored in the biomass—for energy crops (Brassica carinata) grown in Spain. However, the calculations were for experimental plots only. In a more recent study, Murphy et al. [46] examined the energy return for Miscanthus grown in Ireland. They calculated far lower EROEI values, ranging from 3.6 to 6.5, with different fertilizers and different fertilizer transport distances (50 or 100 km) accounting for the variation.
Bioenergy can also be upgraded and used for liquid fuels, but reported EROEI values are low. De Castro et al. [47] examined the EROEI for liquid fuels made from food crops. For bioethanol, the values were 1.25 for US corn ethanol, 5.0 for Brazilian sugar cane ethanol, and for biodiesel, 1.5-3.0. Wang et al. [48], reported comparable values of 1.61 for corn and 4.32 for sugar cane ethanol, but higher values (up to 6.01) for cellulosic ethanol.
The variation in EROEI values reported here is to be expected, given the different bioenergy crops examined, and the fact that different areas will have varying soil fertility and rainfall. But in general, lower EROEI values are more likely, for two reasons. First, even analyses based on field crops often omit necessary energy inputs. Second, analyses often implicitly ignore the "food first"approach, using results from premium agricultural soils.
Assessing the global technical potential for bioenergy is difficult and ambiguous, as the research discussed in this section will show. But it is also important, since we need to know in general whether bioenergy can be a major future energy source, or merely a marginal one. Further, if bioenergy potential is small, it can never be more than a minor climate mitigation solution, even if GHG reductions per EJ of fossil fuel energy replaced were large. But while technical potential estimates increasingly take into detailed account future food needs, the question of biomass-based materials is largely ignored. Implicitly, despite some discussion in the literature on increasing biomaterials use, not much change from present trends is presumably expected. Further, the need for an adequate energy surplus, as discussed in Section 5.1, is also often ignored.
Global bioenergy potential consists of two very different parts. First, energy can be produced from dedicated plantations of fast-growing trees such as willows, eucalypts and poplars; from perennial grasses such as switchgrass and Miscanthus [49]; or from conventional food crops such as cereals, sugar cane and oil seeds. Second, wastes from agriculture and forestry, food wastes, municipal garbage, etc. can also be used for fuel. Over the past two decades, many estimates for the technical potential (both national and global) from both energy crops and wastes have been published, a selection of which are discussed here.
Smeets et al. [12] published in 2007 a detailed review of global potential from dedicated crops using a bottom-up approach. They calculated a global potential of 215-1272 EJ per year. The key variable that would enable bioenergy to play a major role by year 2050 was improvement in agricultural productivity, since the authors assumed that only land surplus to agricultural needs could be used for bioenergy crop production. An additional 150-170 EJ was assumed to be available annually from forest growth or forestry and agricultural residues, for a total of 365-1442 EJ. Earlier research had calculated an even higher potential, 1546 EJ per year [50]. These figures of 1442 and 1546 EJ suggest that bioenergy alone could satisfy human primary energy needs for the foreseeable future. However, they are well in excess of the 900-940 upper limit derived for all biomass from HANPP considerations (see Section 2), and are thus clearly far too optimistic.
On the other hand, some researchers have seen a much reduced role for biomass [50,51,52,53,54,55,56,57], with values as low as 27 EJ or less. Searle and Malins [50], also for the year 2050, estimated that "the maximum limit to long-term total biomass availability is 60-120 EJ yr−1 in primary energy". Most of this potential would come from bioenergy plantations, with only about 20 EJ from various waste sources. Smith et al. [51] similarly looked at the maximum potential contribution that bioenergy could realistically make to year 2050 energy needs, and found a range from about 60 to 180 EJ, or 5% to 15% of all year 2050 estimated primary energy use. For Canadell and Schulze [58], bioenergy could deliver between 26 and 64 EJ per year of primary energy by 2050. Creutzig and colleagues [49] concluded that bioenergy could annually supply 10-245 EJ primary energy by 2050. While 245 EJ represents almost half of 2014 global primary energy use [3], 10 EJ is a trivial share.
The reasons given for this spread in potential are varied. Johnston et al. [52] mainly stressed that bioenergy crop yields (in tonnes per hectare) have been over-estimated, in many cases by 100% or more. Searle and Malins [54] have reached similar conclusions, because of such factors as crop losses and "edge effects in small plots" over-estimating real world harvests. For others, it is the need to preserve biological diversity [15,44] and crucial ecosystem services [50], or the lack of suitable land for energy crops [51]. For Davis et al. [57] who approach the question of bioenergy potential from an ecologically-informed viewpoint, global estimates become systematically smaller as needed limiting factors are progressively applied.
Others have cast doubt on the efficacy of using crop residues and forest wastes. Karlen et al. [59] argued that their use is simply another case of "attempting to solve one environmental problem by inadvertedly creating another." They stress the multiple ecosystem services that crop residues provide: "filtering and storing water; decomposing chemical residues and toxicants; carbon capture and sequestration/storage (CCS) and the same for nitrogen (N); providing wildlife habitat; mitigating flooding; soil, water, and air quality; food, feed, fiber, and energy production; and community development."
This optimal fraction of waste residues to remove from agricultural fields and forests has an analogy in the optimal fraction for HANPP, discussed earlier. Past a certain removal fraction of residue, extra fertilizer will need to be added to the fields to replace the nutrients removed, with an attendant increase in both this energy-intensive input and emissions of N2O [25]. Soil losses from wind and water erosion would also rise, depending on local factors such as terrain slope, local meteorology and soil type, lowering yields and hence residues available for bioenergy.
In summary, the question: "What is the global potential for bioenergy?" has no definitive answer. Hoogwijk et al. [28] have given a list of reasons for why this is the case: "Crucial factors determining biomass availability for energy are: (1) The future demand for food, determined by the population growth and the future diet; (2) The type of food production systems that can be adopted world-wide over the next 50 years; (3) Productivity of forest and energy crops; (4) The (increased) use of bio-materials; (5) Availability of degraded land; (6) Competing land use types, e.g. surplus agricultural land used for reforestation."
The requirement for positive net energy return in the case of bioenergy is today increasingly joined by a new one—the need for climate change mitigation. This requirement is the motivation behind the European Union (EU) directive that member states should obtain 20% of their energy from renewable energy (RE) sources by 2020 [60].
For simplicity, many analyses of RE only consider CO2 emissions for comparison with fossil fuels. This makes sense for fossil fuels combustion, since emissions of other GHGs usually add only a few percent to CO2-eq emissions. (However, for natural gas, the advantage of relatively low CO2 from combustion may be considerably offset by gas leakage from pipes [61], by high CO2 content of some gas fields—as high as 70% in the Natuna gas field in Indonesia [62]—and from tight gas released by hydraulic fracturing). For wind energy and solar energy, nearly all GHG emissions arise from the CO2 from input fossil fuels, together with a small contribution from site clearance. For some other RE sources, emissions of non-CO2 GHGs can be very important. Hydro dams in the tropics with reservoirs that flood forests can have high emissions of both CH4 and CO2 as the vegetation decays [63]. Geothermal energy can also directly emit small amounts of both CH4 and CO2, although for both hydro and geothermal, background emissions of these gases should be established to assess their true climate change effect. For biomass, it is likewise important to consider all GHG emissions, because emissions of N2O and CH4 can be significant [23]. Accordingly, the net energy delivered per kg of CO2 equivalent (CO2-eq) emitted must as a minimum exceed that for the (fossil) fuel it is intended to replace. For example, corn ethanol must lower CO2-eq emissions per MJ of fuel in the vehicle tank compared with those for petrol.
A further important question is how the available biomass should be used to maximise its carbon reduction potential. Should biomass not be used as fuel at all, but simply buried to sequester carbon? Or, should biomass be directly used for bioenergy, perhaps with carbon capture and sequestration (BECCS), to leverage its climate change mitigation? Or, should much non-food biomass first be used for biomaterials, then, if feasible, later combusted for bioenergy? We examine each of these options below.
Zeng [64] has advocated that biomass should be simply buried deep underground. His idea would be "to thin forests regularly, and to bury excess wood, forestry waste and even trees that have been grown specifically to be buried in trenches between remaining trees" [65]. According to Zeng's calculations: "if we buried half of the wood that grows each year, in such a way that it didn't decay, enough CO2 would be removed from the atmosphere to offset all of our fossil-fuel emissions" [65]. One risk is that CH4 would be generated and released from the buried biomass by soil bacteria. And even if no decay occurred, nutrients would no longer be recycled to the forest, so fertilization may be needed.
A related approach, as promoted by Strand and Benford [66], would see agricultural crop residues collected, baled, transported and sequestered on the deep ocean floor (at depths > 1000-1500 m), weighed down with stone ballast if needed. The authors claimed that the "carbon sequestration efficiency" would be over 90%, compared with only 15% if the residues were left in the fields. But as discussed in Section 5.1, Karlen et al. [59], in a rejoinder article, have cast doubt on the efficacy of removing residues from the field for any purpose. Liska et al. [67] have likewise cautioned against use of crop redsidues, stressing loss of soil carbon. Their arguments would also apply to land waste burial.
Finally, these approaches are of no use for providing alternatives to fossil fuels; they are only useful for atmospheric carbon reductions. This point is important, since it is possible that, given a continuation of present trends, in a few decades time we will experience depletion of all but hard-to-extract fossil fuel reserves [1].
Sanchez et al. [41], in their review of bioenergy climate mitigation potential in "western North America" showed that monetary costs for biomass feedstock for electricity production varied by an order of magnitude, with forest and agricultural residues far cheaper than dedicated feedstocks. This price variation suggests that CO2 reduction potential (and its monetary costs) will show similar variation. Large reduction potential per MJ of energy would be expected in the case of methane extraction from municipal landfills or from sewage treatment plants. In such cases bioenergy receives a "double credit" for climate mitigation, since it can both reduce fossil fuel use and also negate the climate change effects of the methane emissions thereby avoided [10].
Many studies have examined the carbon reductionbenefits of the US and Brazilian ethanol programs. These studies are important, since the data are derived from large-scale actual programs, rather than results derived from experimental plots or mathematical models. For the US corn ethanol program, Wang and colleagues [48], using the GREET model, found that liquid biofuels for transport reduced GHG emissions compared with petrol, even when indirect effects from land use changes were included. Their results showed, however, that corn ethanol still released roughly 50-80% of the CO2-eq per MJ that petrol did.
On the other hand, an increasing number of researchers are questioning the climate mitigation benefits of bioenergy, at least in some circumstances. Searchinger et al. [68] have argued that the indirect effects on land use of using food crops for bioenergy greatly reduce bioenergy carbon mitigation. For Smith et al. [23], emissions from soils of nitrous oxide (N2O)—a powerful and long-lasting GHG—would itself largely negate any carbon reduction benefits. West et al. [69] have further pointed out that if the new land needed for agriculture is in the tropics, as is likely, the soil carbon losses will be far higher than if the same amount of food was grown on temperate regions. Popp et al. [70] have also stressed the uncertainty surrounding the GHG reduction potential of bioenergy.
Roder et al. [71] examined whether bioenergy in the form of wood pellets from forest residues imported as a power station fuel to the UK from the USA, actually gave any carbon mitigation benefits at all. They concluded as follows: "The calculations showed in the best case results in GHG reductions of 83% compared to coal-fired electricity generation. When parameters such as different drying fuels, storage emission, dry matter losses and feedstock market changes were included, the bioenergy emission profiles showed strong variation with up to 73% higher GHG emissions compared to coal. " The lower yields per hectare found by Searle and Malins [54] also imply both much lower net energy return and carbon mitigation benefits.
Should biomass be converted to liquid transport fuels, or used as a power station fuel, perhaps with combined heat and power (CHP)? At present, more bioenergy is converted to liquid fuels (ethanol and diesel) than is used as a power station or CHP fuel [2,3]. As already noted, energy security, rural incomes and urban air pollution reduction were important factors driving corn ethanol production in the US, in addition to CO2-eq reductions noted by Wang et al. [48]. However, Campbell et al. [72] have made the case that greater climate benefits can be obtained for road transport if biomass is used to produce electricity instead: "Bioelectricity produces an average of 81% more transportation kilometres and 108% more emissions offsets per unit area of cropland than does cellulosic ethanol." So, just as change of diet would enable greater carbon reductions from bioenergy, so would change in end use of cellulosic fuels from liquid transport fuels to electricity production.
Sanchez et al. [41] have argued that "BECCS may be one of the few cost effective carbon-negative opportunities available should anthropogenic climate change be worse than anticipated or emissions reductions in other sectors prove particularly difficult." In research done for the latest IPCC report, van Vuuren et al. [73] modelled the RCP2.6 pathway, designed to limit average global temperature increases to 2 °C above pre-industrial. They also envisaged a major role for bioenergy in climate mitigation, and particularly for BECCS, along with CCS for remaining fossil fuel use over the present century. BECCS was seen as greatly extending bioenergy's role in climate mitigation. Creutzig et al. [49] have assembled data showing how bioenergy plantation feedstock for electricity production can have far greater CO2-eq reduction per MJ of electricity compared with fossil fuel electricity if BECCS is also used. Compared with modern coal-fired electricity plants, bioelectricity plants, both without CCS, resulted in reductions of from 0.165-0.245 kg CO2-eq per MJ of electricity, depending on biomass feedstock. When both plants were provided with CCS, the corresponding reduction figure rose to 0.22-0.27 kg.
If BECCS is implemented, the energy costs of capturing and permanently storing bioenergy CO2 emissions will reduce the net energy available from biomass, but enhance its CO2-eq reductions. For climate mitigation, whether employing BECCS increases or reduces net GJ/tonne CO2-eq is the relevant question. However, BECCS implies that CCS for fossil fuels is also feasible from technical, political, and economic viewpoints. If it is, BECCS will then need to compete with fossil fuels, especially coal, since the CCS technology and costs are identical for the two fuels, and indeed, for co-firing, would occur in the same power plant. Anderson [74] has, however, cautioned about relying on BECCS, an untried technology, as a major plank in climate mitigation. In fact, geological sequestration of CO2 in general faces many serious problems [1], which perhaps helps explain why no large-scale CCS-equipped generating plants are in operation.
In Section 4 it was shown that although biomaterials were losing share in the construction sector, their use instead of concrete, steel, or other construction materials would often allow a given building function to be met at a lower CO2-eq cost, resulting in lower overall emissions from the construction sector in general. In addition, to a far greater extent than, for example, concrete, timber can often be recycled for re-use as a building material. Steel can also be recycled of course, but its reprocessing still involves major energy and GHG costs.
Two questions arise in combusting biomaterial wastes. First, would collection and transport costs negate any further GHG reduction benefits? Cities have both high areal intensities of both materials use (tonne/km2) and energy use GJ/km2), and further incur substantial waste collection and disposal costs. Transport costs should therefore be minor, and would be offset by reduced waste to landfill transport costs. Second, to what extent would the often toxic preservatives and bonding agents used for biomaterials reduce the quantity available for combustion? Pizzi [75] has shown, however, that non-toxic substitutes are available for both preservatives and bonding agents.
In addition to the issues already raised in Sections 6.1-6.3, an important factor to consider in assessing the different approaches to its use is the time taken to achieve the mitigation outcome [76]. Time-to-harvest will be shortest for biofuel production, given that this typically uses feedstocks consisting of seasonal crops (eg sugar cane, corn, palm, rapeseed). For woody biomass, which can be used as a substitute material in buildings, and later for energy production, time-to-harvest will depend on species type, land quality and the ultimate purpose of the material (eg manufactured and engineered timbers, structural timber, cladding, panelling, decking). Plantation timber harvest times range from 10 to 60 years, with longer times generally needed to achieve the log size suitable for structural timber. An as example, radiata pine, a fast growing softwood species commonly used in the housing construction sector, is typically harvested after 30 to 35 years of its initial planting [77]. During the growth period, lower grade timber is harvested from these plantations during pruning and thinning operations; this timber could be used directly as a bioenergy feedstock if deemed unsuitable for wood products. The proportion of the plantation harvested in this manner depends entirely on the ultimate use of the dominant plantation product [77].
The time taken to achieve the additional benefit in CO2 mitigation by material substitution will depend on the life of the building in which it is used. For residential housing, although there will be refurbishment throughout its life, it could take up to 100 years to release the structural wood (eg floor, ceiling and walls) for final use in energy production [76]. Depending of type of antifungal treatment used, timber used externally (eg decking, fencing and cladding), could be released for energy production much sooner.
Table 4 presents a summary of the foregoingdiscussion, and also includes an indication of the potential EROEI for the biomass utilisation pathway.
Biomass ultilizationpathway | Atmospheric removal of CO2 | Reduction in CO2 emissions by material substitution | Reduction in CO2 emissions by fuel substitution | EROEI |
Burial | X | Negative | ||
Bioenergy (inc. biofuels) | X | Low to medium | ||
Material + burial | X | X | Low | |
Material + bioenergy | X | X | Medium | |
Material + bioenergy + CCS | X | X | X | Low to medium |
Humans use biomass products for food, fodder, energy and materials, but their combined use may already be near limits. Further, on-going climate change could change NPP at various scales, either through temperature or rainfall changes. The likely future climate changes will on balance negatively affect yields [78], and thus biomass potential [79]. Hence the important question addressed in this review: How should non-food biomass be deployed to maximise reductions in GHGs?
The use of biomass for biomaterials has been largely ignored, the implicit assumption being that it will continue to lose market share. But increasing biomaterials' share of the materials market can in many cases reduce GHG emissions by displacing production of more energy-intensive (and GHG- intensive) competing materials such as concrete and steel, or artificial fibres. However, it will not necessarily achieve greater GHG reductions than directly using the biomass for energy, which also displaces fossil fuels. We have argued here for dual use of non-food biomass, first using biomass for various materials applications, perhaps followed by reuse, then finally combusting it for energy at the end of its useful life. Dual use would potentially enable such bioenergy to pass the EROEI test, since only the extra energy (and GHG) costs involved in collection are relevant. Since even food production generates wastes, some of which at least can be used for energy, the different uses for biomass can partly conflict, partly complement each other.
This review has made little mention of monetary costs of biomaterials or bioenergy compared with alternatives. The reason is that today's costs may be a poor guide to future costs, particularly if carbon taxes are introduced. If these taxes were high, the monetary costs of using biomass for materials and/or energy would compare more favourably with alternatives. Fossil fuels also receive very high subsidies globally [80].
The conclusion is that the scope of analysis for bioenergy's global potential and carbon mitigation potential has to be widened even further. The global potential for bioenergy in recent decades would have risen because of the declining global market share of biomass materials. Evaluating the carbon reduction potential of biomass is now seen to require consideration of global GHG emissions from both the entire non-food biomass system and from the non-biomass materials sector (as well as the GHG costs of biomaterials waste disposal). However, the emissions reduction from final combustion of biomaterials could be delayed for decades, too late if reductions in GHGs are urgently needed.
A useful analogy may be water recycling [81]. In the face of looming water shortages, some researchers propose reusing water in a series of uses, with each successive use needing lower water quality. Finally, after the water is piped to a treatment plant, the cycle is repeated. For construction timber, reuse for construction or other material use is also often possible, with final combustion for energy analogous to the water treatment plant, although unlike water, no further reuse is possible after combustion.
All authors declare no conflicts of interest in this paper.
[1] |
Das S, Dawson NL, Orengo RA (2015) Diversity in protein domain superfamilies. Curr Opin Genet Dev 35: 40–49. doi: 10.1016/j.gde.2015.09.005
![]() |
[2] |
Giuroiu I, Weber J (2017) Novel checkpoints and cosignaling molecules in cancer immunotherapy. Cancer J 23: 23–31. doi: 10.1097/PPO.0000000000000241
![]() |
[3] |
Wei SC, Levine JH, Cogdill AP, et al. (2017) Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170: 1120–1133. doi: 10.1016/j.cell.2017.07.024
![]() |
[4] | Murmann AE, McMahon KM, Haluck-Kangas A, et al. (2017) Induction of DISE in ovarian cancer cells in vivo. Oncotarget 8: 84643–84658. |
[5] |
Buchbinder E, Desai A (2016) CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol 39: 98–106. doi: 10.1097/COC.0000000000000239
![]() |
[6] | Rotte A, Jin JY, Lemaire V (2017) Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy. Ann Oncol. |
[7] |
Zelensky AN, Gready JE (2005) The C-type lectin-like domain superfamily. FEBS J 272: 6179–6217. doi: 10.1111/j.1742-4658.2005.05031.x
![]() |
[8] |
Geijtenbeek TB, Gringhuis SI (2009) Signaling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9: 465–479. doi: 10.1038/nri2569
![]() |
[9] |
García-Vallejo JJ, Van KY (2009) Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol Rev 230: 22–37. doi: 10.1111/j.1600-065X.2009.00786.x
![]() |
[10] |
Van KY, Ilarregui JM, van Vliet SJ (2015) Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL. Immunobiology 220: 185–192. doi: 10.1016/j.imbio.2014.10.002
![]() |
[11] |
Sancho D, Reis SC (2013) Sensing of cell death by myeloid C-type lectin receptors. Curr Opin Immunol 25: 46–52. doi: 10.1016/j.coi.2012.12.007
![]() |
[12] |
Chang SY, Kweon MN (2010) Langerin-expressing dendritic cells in gut-associated lymphoid tissues. Immunol Rev 234: 233–246. doi: 10.1111/j.0105-2896.2009.00878.x
![]() |
[13] |
Ingeborg SO, Unger WWJ, Yvette VK (2011) C-type lectin receptors for tumor eradication: future directions. Cancers 3: 3169–3188. doi: 10.3390/cancers3033169
![]() |
[14] |
Zhang F, Ren S, Zuo Y (2014) DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection. Int Rev Immunol 33: 54–66. doi: 10.3109/08830185.2013.834897
![]() |
[15] | Yan H, Kamiya T, Suabjakyong P, et al. (2015) Targeting C-type lectin receptors for cancer immunity. Front Immunol 6: 408–416. |
[16] |
Dambuza IM, Brown GD (2015) C-type lectins in immunity: recent developments. Curr Opin Immunol 32: 21–27. doi: 10.1016/j.coi.2014.12.002
![]() |
[17] | Ding D, Yao Y, Zhang S, et al. (2017) C-type lectins facilitate tumor metastasis. Oncol Lett 13: 13–21. |
[18] |
Andersen CBF, Moestrup SK (2014) How calcium makes endocytic receptors attractive. Trends Biochem Sci 39: 82–90. doi: 10.1016/j.tibs.2013.12.003
![]() |
[19] | Eggensperger A, Tampé R (2015) The transporter associated with antigen processing: a key player in adaptive immunity. Biol Chem 396: 1059–1072. |
[20] |
Rodriguez A, Regnault A, Kleijmeer M, et al. (1999) Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1: 362–368. doi: 10.1038/14058
![]() |
[21] |
Solheim JC (1999) Class I MHC molecules: assembly and antigen presentation. Immunol Rev 172: 11–19. doi: 10.1111/j.1600-065X.1999.tb01352.x
![]() |
[22] |
Gil-Torregrosa BC, Lennon-Duménil AM, Kessler B, et al. (2004) Control of cross-presentation during dendritic cell maturation. Eur J Immunol 34: 398–407. doi: 10.1002/eji.200324508
![]() |
[23] |
Heath WR, Carbone FR (2001) Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1: 126–135. doi: 10.1038/35100512
![]() |
[24] |
Joffre OP, Segura E, Savina A, et al. (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12: 557–569. doi: 10.1038/nri3254
![]() |
[25] | McDonnell AM, Robinson BWS, Currie AJ (2010) Tumor antigen cross-presentation and the dendritic cell: where it all begins? Clin Dev Immunol 2010: 539519–539527. |
[26] | Bousso P, Robey E (2003) Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 4: 579–585. |
[27] |
Randolph GJ, Jakubzick C, Qu C (2008) Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol 20: 52–60. doi: 10.1016/j.coi.2007.10.010
![]() |
[28] |
Leiri?o P, Fresno CD, Ardavín C (2012) Monocytes as effector cells: activated Ly-6C(high) mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells. Eur J Immunol 42: 2042–2051. doi: 10.1002/eji.201142166
![]() |
[29] |
Raghavan M, Wijeyesakere SJ, Peters LR, et al. (2013) Calreticulin in the immune system: ins and outs. Trends Immunol 34: 13–21. doi: 10.1016/j.it.2012.08.002
![]() |
[30] |
Lv D, Shen Y, Peng Y, et al. (2015) Neuronal MHC class I expression is regulated by activity driven calcium signaling. PLoS One 10: e0135223–e0135238. doi: 10.1371/journal.pone.0135223
![]() |
[31] | Skov S (1999) Intracellular signal transduction mediated by ligation of MHC class I molecules. Tissue Antigens 51: 215–223. |
[32] |
Blum JS, Wearsch PA, Cresswell P (2013) Pathways of antigen processing. Annu Rev Immunol 31: 443–473. doi: 10.1146/annurev-immunol-032712-095910
![]() |
[33] |
Roche PA, Furuta K (2015) The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol 15: 203–216. doi: 10.1038/nri3818
![]() |
[34] |
Mueller SN (2017) Spreading the load: antigen transfer between migratory and lymph node-resident dendritic cells promotes T-cell priming. Eur J Immunol 47: 1798–1801. doi: 10.1002/eji.201747248
![]() |
[35] |
Parton RG, Joggerst B, Simons K (1994) Regulated internalization of caveolae. J Cell Biol 127: 1199–1215. doi: 10.1083/jcb.127.5.1199
![]() |
[36] |
Levine TP, Chain BM (1992) Endocytosis by antigen presenting cells: dendritic cells are as endocytically active as other antigen presenting cells. Proc Natl Acad Sci USA 89: 8342–8346. doi: 10.1073/pnas.89.17.8342
![]() |
[37] |
Hohn C, Lee SR, Pinchuk LM, et al. (2009) Zebrafish kidney phagocytes utilize macropinocytosis and Ca+-dependent endocytic mechanisms. PLoS One 4: e4314–e4323. doi: 10.1371/journal.pone.0004314
![]() |
[38] |
Calmette J, Bertrand M, Vétillard M, et al. (2016) Glucocorticoid-induced leucine zipper protein controls macropinocytosis in dendritic cells. J Immunol 197: 4247–4256. doi: 10.4049/jimmunol.1600561
![]() |
[39] |
Ayroldi E, Riccardi C (2009) Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 23: 3649–3658. doi: 10.1096/fj.09-134684
![]() |
[40] | Ronchetti S, Migliorati G, Riccardi C (2015) GILZ as a mediator of the anti-inflammatory effects of glucocorticoids. Front Endocrinol 6: 170–175. |
[41] |
Canton J, Schlam D, Breuer C, et al. (2016) Calcium-sensing receptors signal constitutive macropinocytosis and facilitate the uptake of NOD2 ligands in macrophages. Nat Commun 7: 11284–11295. doi: 10.1038/ncomms11284
![]() |
[42] | Redka DS, Gütschow M, Grinstein S, et al. (2017) Differential ability of pro-inflammatory and anti-inflammatory macrophages to perform macropinocytosis. Mol Biol Cell pii: mbc.E17-06-0419. |
[43] | Carafoli E, Krebs J (2016) Why calcium? How calcium became the best communicator. J Biol Chem 291: 20849–20857. |
[44] |
Caroppo R, Gerbino A, Fistetto G, et al. (2004) Extracellular calcium acts as a "third messenger" to regulate enzyme and alkaline secretion. J Cell Biol 166: 111–119. doi: 10.1083/jcb.200310145
![]() |
[45] | Drickamer K (1988) Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem 263: 9557–9560. |
[46] |
Drickamer K (1996) Ca(2+)-dependent sugar recognition by animal lectins. Biochem Soc T 24: 146–150. doi: 10.1042/bst0240146
![]() |
[47] |
Weis WI, Taylor ME, Drickamer K (1998) The C-type lectin superfamily in the immune system. Immunol Rev 163: 19–34. doi: 10.1111/j.1600-065X.1998.tb01185.x
![]() |
[48] |
Drickamer K, Taylor ME (2015) Recent insights into structures and functions of C-type lectins in the immune system. Curr Opin Struc Biol 34: 26–34. doi: 10.1016/j.sbi.2015.06.003
![]() |
[49] |
van Vliet SJ, Saeland E, Van KY (2008) Sweet preferences of MGL: carbohydrate specificity and function. Trends Immunol 29: 83–90. doi: 10.1016/j.it.2007.10.010
![]() |
[50] |
Van DD, Stolk DA, Van RVD, et al. (2017) Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines. J Leukocyte Biol 102: 1017–1034. doi: 10.1189/jlb.5MR0217-059RR
![]() |
[51] |
Napoletano C, Zizzari IG, Rughetti A, et al. (2012) Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation. Eur J Immunol 42: 936–945. doi: 10.1002/eji.201142086
![]() |
[52] |
Engering A, Geijtenbeck TBH, van Vliet SJ, et al. (2002) The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 168: 2118–2126. doi: 10.4049/jimmunol.168.5.2118
![]() |
[53] | Database of human proteins containing CTLDs. Available from: http://www.imperial.ac.uk/research/animallectins/ctld/mammals/humandata%20updated.html. |
[54] | Cummings RD, McEver RP (2017) Chapter 34: C-Type lectins, In: Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology 3rd Ed. Cold Spring Harbor Laboratory Press, 2015–2017. |
[55] |
Sancho D, Reis SC (2012) Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 30: 491–529. doi: 10.1146/annurev-immunol-031210-101352
![]() |
[56] |
Billadeau DD, Leibson PJ (2002) ITAMs versus ITIMs: striking a balance during cell regulation. J Clin Invest 109: 161–168. doi: 10.1172/JCI0214843
![]() |
[57] |
Ivashkiv LB (2009) Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 10: 340–347. doi: 10.1038/ni.1706
![]() |
[58] |
Bezbradica JS, Rosenstein RK, DeMarco RA, et al. (2014) A role for the ITAM signaling module in specifying cytokine-receptor functions. Nat Immunol 15: 333–342. doi: 10.1038/ni.2845
![]() |
[59] |
Pollitt AY, Poulter NS, Gitz E, et al. (2014) Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells. J Biol Chem 289: 35695–35710. doi: 10.1074/jbc.M114.584284
![]() |
[60] |
Unkeless JC, Jin J (1997) Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol 9: 338–343. doi: 10.1016/S0952-7915(97)80079-9
![]() |
[61] |
van Vliet SJ, Aarnoudse CA, Vc BDB, et al. (2007) MGL-mediated internalization and antigen presentation by dendritic cells: a role for tyrosine-5. Eur J Immunol 37: 2075–2081. doi: 10.1002/eji.200636838
![]() |
[62] | Harris RL, Cw VDB, Bowen DJ (2012) ASGR1 and ASGR2, the genes that encode the asialoglycoprotein receptor (Ashwell Receptor), are expressed in peripheral blood monocytes and show inter-individual differences in transcript profile. Mol Biol Int 2012: 283974–283983. |
[63] |
East L, Isacke CM (2002) The mannose receptor family. BBA-Gen Subjects 1572: 364–386. doi: 10.1016/S0304-4165(02)00319-7
![]() |
[64] | Uniport. Available from: http://www.uniprot.org/uniprot/P22897. |
[65] |
Lo YL, Liou GG, Lyu JH, et al. (2016) Dengue virus infection is through a cooperative interaction between a mannose receptor and CLEC5A on macrophage as a multivalent hetero-complex. PLoS One 11: e0166474–e0166486. doi: 10.1371/journal.pone.0166474
![]() |
[66] | R?dgaard-Hansen S, Rafique A, Christensen PA, et al. (2014) A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clin Chem Lab Med 52: 453–461. |
[67] |
Feinberg H, Park-Snyder S, Kolatkar AR, et al. (2000) Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor. J Biol Chem 275: 21539–21548. doi: 10.1074/jbc.M002366200
![]() |
[68] |
Ng KKS, Park-Snyder S, Weis WI (1998) Ca2+-dependent structural changes in C-type mannose-binding proteins. Biochemistry 37: 17965–17976. doi: 10.1021/bi981972a
![]() |
[69] | Iobst ST, Wormald MR, Weis WI, et al. (1994) Binding of sugar ligands to Ca(2+)-dependent animal lectins. I. Analysis of mannose binding by site-directed mutagenesis and NMR. J Biol Chem 269: 15505–15511. |
[70] |
Weis WI, Drickamer K, Hendrickson WA (1992) Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360: 127–134. doi: 10.1038/360127a0
![]() |
[71] |
Drickamer K (1992) Engineering galactose-binding activity into a C-type mannose-binding protein. Nature 360: 183–186. doi: 10.1038/360183a0
![]() |
[72] |
Apostolopoulos V, Pietersz GA, Loveland, BE, et al. (1995) Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci USA 92: 10128–10132. doi: 10.1073/pnas.92.22.10128
![]() |
[73] |
Apostolopoulos V, Pietersz GA, Gordon S, et al. (2000) Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur J Immunol 30: 1714–1723. doi: 10.1002/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C
![]() |
[74] |
Apostolopoulos V, Pietersz GA, Tsibanis A, et al. (2014) Dendritic cell immunotherapy: clinical outcomes. Clin Transl Immunol 3: e21–e24. doi: 10.1038/cti.2014.14
![]() |
[75] |
Steinman RM, Turley S, Mellman I, et al. (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191: 411–416. doi: 10.1084/jem.191.3.411
![]() |
[76] |
Steinman RM, Hawiger D, Liu K, et al. (2003) Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann Ny Acad Sci 987: 15–25. doi: 10.1111/j.1749-6632.2003.tb06029.x
![]() |
[77] |
Redmond WL, Sherman LA (2005) Peripheral tolerance of CD8 T lymphocytes. Immunity 22: 275–284. doi: 10.1016/j.immuni.2005.01.010
![]() |
[78] |
Chieppa M, Bianchi G, Doni A, et al. (2003) Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 171: 4552–4560. doi: 10.4049/jimmunol.171.9.4552
![]() |
[79] | Allavena P, Chieppa M, Blanchi G, et al. (2010) Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol 2010: 547179–547188. |
[80] |
Sharpe AH (2009) Mechanisms of costimulation. Immunol Rev 229: 5–11. doi: 10.1111/j.1600-065X.2009.00784.x
![]() |
[81] |
Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13: 227–242. doi: 10.1038/nri3405
![]() |
[82] |
Anderson PJ, Kokame K, Sadler JE (2006) Zinc and calcium ions cooperatively modulate ADAMTS13 activity. J Biol Chem 281: 850–857. doi: 10.1074/jbc.M504540200
![]() |
[83] | Sorvillo N, Pos W, Lm VDB, et al. (2017) The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cells. Blood 119: 3828–3835. |
[84] |
Mahnke K, Guo M, Lee S, et al. (2000) The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 151: 673–683. doi: 10.1083/jcb.151.3.673
![]() |
[85] |
Platt CD, Ma JK, Chalouni C, et al. (2010) Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Nat Acad Sci USA 107: 4287–4292. doi: 10.1073/pnas.0910609107
![]() |
[86] |
Tel J, Benitez-Ribas D, Hoosemans S, et al. (2011) DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. Eur J Immunol 41: 1014–1023. doi: 10.1002/eji.201040790
![]() |
[87] |
Hawiger D, Inaba K, Dorsett Y, et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194: 769–779. doi: 10.1084/jem.194.6.769
![]() |
[88] |
Ma DY, Clark EA (2009) The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 21: 265–272. doi: 10.1016/j.smim.2009.05.010
![]() |
[89] |
Lee GH, Askari A, Malietzis G, et al. (2014) The role of CD40 expression in dendritic cell in cancer biology: a systematic review. Curr Cancer Drug Tar 14: 610–620. doi: 10.2174/1568009614666140828103253
![]() |
[90] |
Sartorius R, D'Apice L, Trovato M, et al. (2015) Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. Embo Mol Med 7: 973–988. doi: 10.15252/emmm.201404525
![]() |
[91] |
Melander MC, Jürgensen HJ, Madsen DH, et al. (2015) The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review). Int J Oncol 47: 1177–1188. doi: 10.3892/ijo.2015.3120
![]() |
[92] |
Sturge J (2016) Endo180 at the cutting edge of bone cancer treatment and beyond. J Pathol 238: 485–488. doi: 10.1002/path.4673
![]() |
[93] |
Yuan C, Jürgensen HJ, Engelholm LH, et al. (2016) Crystal structures of the ligand-binding region of uPARAP: effect of calcium ion binding. Biochem J 473: 2359–2368. doi: 10.1042/BCJ20160276
![]() |
[94] |
East L, Rushton S, Taylor ME, et al. (2002) Characterization of sugar binding by the mannose receptor family member, Endo180. J Biol Chem 277: 50469–50475. doi: 10.1074/jbc.M208985200
![]() |
[95] |
Augert A, Payré C, de Launoit Y, et al. (2009) The M-type receptor PLA2R regulates senescence through the p53 pathway. Embo Rep 10: 271–277. doi: 10.1038/embor.2008.255
![]() |
[96] |
Jr BLH, Bonegio RG, Lambeau G, et al. (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med 361: 11–21. doi: 10.1056/NEJMoa0810457
![]() |
[97] |
Takahashi S, Watanabe K, Watanabe Y, et al. (2015) C-type lectin-like domain and fibronectin-like type II domain of phospholipase A2 receptor 1 modulate binding and migratory responses to collagen. Febs Lett 589: 829–835. doi: 10.1016/j.febslet.2015.02.016
![]() |
[98] |
Nolin JD, Ogden HL, Lai Y, et al. (2016) Identification of epithelial phospholipase A2 receptor 1 as a potential target in asthma. Am J Resp Cell Mol 55: 825–836. doi: 10.1165/rcmb.2015-0150OC
![]() |
[99] |
Fresquet M, Jowitt TA, McKenzie EA, et al. (2017) PLA2R binds to the annexin A2-S100A10 complex in human podocytes. Sci Rep 7: 6876–6886. doi: 10.1038/s41598-017-07028-8
![]() |
[100] |
Santamaria-Kisiel L, Rintala-Dempsey A, Shaw GS (2006) Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 396: 201–214. doi: 10.1042/BJ20060195
![]() |
[101] |
Goder V, Spiess M (2001) Topogenesis of membrane proteins: determinants and dynamics. Febs Lett 504: 87–93. doi: 10.1016/S0014-5793(01)02712-0
![]() |
[102] |
Zimmerman R, Eyrisch S, Ahmad M, et al. (2011) Protein translocation across the ER membrane. BBA-Biomembranes 1808: 912–924. doi: 10.1016/j.bbamem.2010.06.015
![]() |
[103] |
Feinberg H, Mitchell DA, Drickamer K, et al. (2001) Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294: 2163–2166. doi: 10.1126/science.1066371
![]() |
[104] | Mitchell DA, Fadden AJ, Drickamer K (2001) A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 276: 28939–28945. |
[105] |
Guo Y, Feinberg H, Conroy E, et al. (2004) Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 11: 591–598. doi: 10.1038/nsmb784
![]() |
[106] |
Caparrós E, Munoz P, Sierra-Filardi E, et al. (2006) DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 107: 3950–3958. doi: 10.1182/blood-2005-03-1252
![]() |
[107] |
Iyori M, Ohtani M, Hasebe A, et al. (2008) A role of the Ca2+ binding site of DC-SIGN in the phagocytosis of E. coli. Biochem Bioph Res Co 377: 367–372. doi: 10.1016/j.bbrc.2008.09.142
![]() |
[108] |
Dos Santos á, Hadjivasiliou A, Ossa F, et al. (2017) Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: sequence variation and stability differences. Protein Sci 26: 306–316. doi: 10.1002/pro.3083
![]() |
[109] |
Dodagatta-Marri E, Mitchell DA, Pandit H, et al. (2017) Protein-protein interaction between surfactant protein D and DC-SIGN via C-type lectin domain can suppress HIV-1 transfer. Front Immunol 8: 834–845. doi: 10.3389/fimmu.2017.00834
![]() |
[110] |
Chao PZ, Hsieh MS, Cheng CW, et al. (2015) Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN. Oncotarget 6: 159–170. doi: 10.18632/oncotarget.2700
![]() |
[111] |
Chia J, Goh G, Bard F (2016) Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives. BBA-Gen Subjects 1860: 1623–1639. doi: 10.1016/j.bbagen.2016.03.008
![]() |
[112] |
Zheng J, Xiao H, Wu R (2017) Specific identification of glycoproteins bearing the Tn antigen in human cells. Angew Chem 129: 7213–7217. doi: 10.1002/ange.201702191
![]() |
[113] |
Feinberg H, Torgersen D, Drickamer K, et al. (2000) Mechanism of pH-dependent N-acetylgalactosamine binding by a functional mimic of the hepatocyte asialoglycoprotein receptor. J Biol Chem 275: 35176–35184. doi: 10.1074/jbc.M005557200
![]() |
[114] | Morell AG, Gregoriadis G, Scheinberg IH, et al. (1971) The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 246: 1461–1467. |
[115] |
Grewal PK (2010) The Ashwell-Morell receptor. Method Enzymol 479: 223–241. doi: 10.1016/S0076-6879(10)79013-3
![]() |
[116] |
Weigel PH, Yik JHN (2002) Glycans as endocytosis signals: the cases of the asialoprotein and hyaluronan/chrondroitin sulfate receptors. BBA-Gen Subjects 1572: 341–363. doi: 10.1016/S0304-4165(02)00318-5
![]() |
[117] | Dixon LJ, Barnes M, Tang H, et al. (2013) Kupffer Cells in the Liver. Compr Physiol 3: 785–797. |
[118] |
Tsuiji M, Fujimori M, Ohashi Y, et al. (2002) Molecular cloning and characterization of a novel mouse macrophage C-type lectin, mMGL2, which has a distinct carbohydrate specificity from mMGL1. J Biol Chem 277: 28892–28901. doi: 10.1074/jbc.M203774200
![]() |
[119] |
Kolatkar AR, Weis WI (1996) Structural basis of galactose recognition by C-type animal lectins. J Biol Chem 271: 6679–6685. doi: 10.1074/jbc.271.12.6679
![]() |
[120] |
Meier M, Bider MD, Malashkevich VN, et al. (2000) Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J Mol Biol 300: 857–865. doi: 10.1006/jmbi.2000.3853
![]() |
[121] |
Higashi N, Fujioka K, Denda-Nagai K, et al. (2002) The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J Biol Chem 277: 20686–20693. doi: 10.1074/jbc.M202104200
![]() |
[122] |
Lundberg K, Rydnert F, Broos S, et al. (2016) C-type lectin receptor expression on human basophils and effects of allergen-specific immunotherapy. Scand J Immunol 84: 150–157. doi: 10.1111/sji.12457
![]() |
[123] |
Vukman KV, Ravidà A, Aldridge AM, et al. (2013) Mannose receptor and macrophage galactose-type lectin are involved in Bordetella pertussis mast cell interaction. J Leukocyte Biol 94: 439–448. doi: 10.1189/jlb.0313130
![]() |
[124] |
Savola P, Kelkka T, Rajala HL, et al. (2017) Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis. Nat Commun 8: 15869–15882. doi: 10.1038/ncomms15869
![]() |
[125] | Gaur P, Myles A, Misra R, et al. (2016) Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis. Clin Exp Immunol 187: 234–241. |
[126] |
Vlismas A, Bletsa R, Mavrogianni D, et al. (2016) Microarray analyses reveal marked differences in growth factor and receptor expression between 8-cell human embryos and pluripotent stem cells. Stem Cells Dev 25: 160–177. doi: 10.1089/scd.2015.0284
![]() |
[127] |
Klimmeck D, Hanssong J, Raffel S, et al. (2012) Proteomic cornerstones of hematopoietic stem cell differentiation: distinct signatures of multipotent progenitors and myeloid committed cells. Molec Cell Proteomics 11: 286–302. doi: 10.1074/mcp.M111.016790
![]() |
[128] |
Winkler C, Witte L, Moraw N, et al. (2014) Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics. BMC Immunol 15: 12–22. doi: 10.1186/1471-2172-15-12
![]() |
[129] |
Mathews JA, Kasahara DI, Ribeiro L, et al. (2015) γδ T cells are required for M2 macrophage polarization and resolution of ozone-induced pulmonary inflammation in mice. PLoS One 10: e0131236–e0131251. doi: 10.1371/journal.pone.0131236
![]() |
[130] |
Shin H, Kumamoto Y, Gopinath S, et al. (2016) CD301b+ dendritic cells stimulate tissue-resident memory CD8+ T cells to protect against genital HSV-2. Nat Commun 7: 13346–13355. doi: 10.1038/ncomms13346
![]() |
[131] |
Linehan JL, Dileepan T, Kashem SW, et al. (2015) Generation of Th17 cells in response to intranasal infection requires TGF-β1 from dendritic cells and IL-6 from CD301b+ dendritic cells. Proc Natl Acad Sci USA 112: 12782–12787. 132. Wong KL, Tai JJ, Wong WC, et al. (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118: e16–e31. doi: 10.1182/blood-2010-12-326355
![]() |
[132] |
133. Wong KL, Yeap WH, Tai JJY, et al. (2012) The three human monocyte subsets: implications for health and disease. Immunol Res 53: 41–57. doi: 10.1007/s12026-012-8297-3
![]() |
[133] |
134. Michlmayr D, Andrade P, Gonzalez K, et al. (2017) CD14+CD16+ monocytes are the main target of Zika virus infection in peripheral blood mononuclear cells in a paediatric study in Nicaragua. Nat Microbiol 2: 1462–1470. doi: 10.1038/s41564-017-0035-0
![]() |
[134] |
135. Knudsen NH, Lee CH (2016) Identity crisis: CD301b(+) mononuclear phagocytes blur the M1-M2 macrophage line. Immunity 45: 461–463. doi: 10.1016/j.immuni.2016.09.004
![]() |
[135] |
136. Zhang W, Xu W, Xiong S (2011) Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component. J Immunol 187: 1764–1777. doi: 10.4049/jimmunol.1002315
![]() |
[136] |
137. Trowbridge IS, Thomas M (1994) CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 12: 85–116. doi: 10.1146/annurev.iy.12.040194.000505
![]() |
[137] | 138. van Vliet SJ, Gringhuis SI, Geijtenbeek TBH, et al. (2006) Regulation of effector T cells by antigen-presenting cells via interaction with the C-type lectin MGL with CD45. Nat Immunol 11: 1200–1208. |
[138] |
139. Nam HJ, Poy F, Saito H, et al. (2005) Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45. J Exp Med 201: 441–452. doi: 10.1084/jem.20041890
![]() |
[139] |
140. Xu Z, Weiss A (2002) Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immunol 3: 764–771. doi: 10.1038/ni822
![]() |
[140] |
141. Kumar V, Cheng P, Condamine T, et al. (2016) CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation. Immunity 44: 303–315. doi: 10.1016/j.immuni.2016.01.014
![]() |
[141] |
142. van Vliet SJ, van Liempt E, Geijtenbeek TB, et al. (2006) Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology 211: 577–585. doi: 10.1016/j.imbio.2006.05.022
![]() |
[142] |
143. Marcelo F, Garcia-Martin F, Matsushita T, et al. (2014) Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin. Chem Eur J 20: 16147–16155. doi: 10.1002/chem.201404566
![]() |
[143] |
144. Tanaka J, Gleinich AS, Zhang Q, et al. (2017) Specific and differential binding of N-acetylgalactosamine glycopolymers to the human macrophage galactose lectin and asialoglycoprotein receptor. Biomacromolecules 18: 1624–1633. doi: 10.1021/acs.biomac.7b00228
![]() |
[144] |
145. Khorev O, Stokmaier D, Schwardt O, et al. (2008) Trivalent, Gal/GaNAc-containing ligands designed for the asialoglycoprotein receptor. Bioorg Med Chem 16: 5216–5231. doi: 10.1016/j.bmc.2008.03.017
![]() |
[145] |
146. Nair JK, Willoughby JLS, Chan A, et al. (2014) Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J Am Chem Soc 136: 16958–16961. doi: 10.1021/ja505986a
![]() |
[146] | 147. Lo-Man R, Bay S, Vichier-Guerre S, et al. (1999) A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy. Cancer Res 59: 1520–1524. |
[147] |
148. Lo-Man R, Vichier-Guerre S, Bay S, et al. (2001) Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope. J Immunol 166: 2849–2854. doi: 10.4049/jimmunol.166.4.2849
![]() |
[148] |
149. Morgan AJ, Platt FM, Lloyd-Evans E, et al. (2011) Molecular mechanisms of endolysosomal Ca2+ signaling in health and disease. Biochem J 439: 349–374. doi: 10.1042/BJ20110949
![]() |
[149] |
150. Wragg S, Drickamer K (1999) Identification of amino acid residues that determine pH dependence of ligand binding to the asialoglyprotein receptor during endocytosis. J Biol Chem 274: 35400–35406. doi: 10.1074/jbc.274.50.35400
![]() |
[150] |
151. Onizuka T, Shimizu H, Moriwaki Y, et al. (2012) NMR study of ligand release from asialoglycoprotein receptor under solution conditions in early endosomes. Febs J 279: 2645–2656. doi: 10.1111/j.1742-4658.2012.08643.x
![]() |
[151] |
152. Gerasimenko JV, Tepikin AV, Petersen OH, et al. (1998) Calcium uptake via endocytosis with rapid release from acidifying endosomes. Curr Biol 8: 1335–1338. doi: 10.1016/S0960-9822(07)00565-9
![]() |
[152] |
153. Plattner H, Verkhratsky A (2016) Inseparable tandem: evolution chooses ATP and Ca2+ to control life, death and cellular signaling. Philos T R Soc B 371: 20150419–20150433. doi: 10.1098/rstb.2015.0419
![]() |
[153] |
154. Napoletano C, Rughetti A, Tarp MPA, et al. (2007) Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res 67: 8358–8367. doi: 10.1158/0008-5472.CAN-07-1035
![]() |
[154] |
155. Hiltbold EM, Vlad AM, Ciborowski P, et al. (2000) The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. J Immunol 165: 3730–3741. doi: 10.4049/jimmunol.165.7.3730
![]() |
[155] |
156. Hanisch FG, Schwientek T, Von BergweltBaildon MS, (2003) O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells. Eur J Immunol 33: 3242–3254. doi: 10.1002/eji.200324189
![]() |
[156] |
157. Freire T, Zhang X, Dériaud E, et al. (2010) Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant. Blood 116: 3526–3536. doi: 10.1182/blood-2010-04-279133
![]() |
[157] |
158. Freire T, Lo-Man R, Bay S, et al. (2011) Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of the Th17-biased T cell responses. J Biol Chem 286: 7797–7811. doi: 10.1074/jbc.M110.209742
![]() |
[158] |
159. Li D, Romain G, Flamar AL, et al. (2012) Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generate IL-10-producing suppressive CD4+ T cells. J Exp Med 209: 109–121. doi: 10.1084/jem.20110399
![]() |
[159] |
160. Valladeau J, Duvert-Frances V, Pin JJ, et al. (2001) Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol 167: 5767–5774. doi: 10.4049/jimmunol.167.10.5767
![]() |
[160] | 161. Garg S, Oran A, Wajchman J, et al. (2003) Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol 4: 907–912. |
[161] | 162. Tomura M, Hata A, Matsuoka S, et al. (2014) Tracking and quantification of dendritic cell migration and antigen trafficking between the skin and lymph nodes. Sci Rep 4: 6030–6040. |
[162] |
163. Kitano M, Yamazaki C, Takumi A, et al. (2016) Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node. Proc Natl Acad Sci USA 113: 1044–1049. doi: 10.1073/pnas.1513607113
![]() |
[163] |
164. Wan YY, Flavell RA (2009) How diverse-CD4 effector T cells and their functions. J Mol Cell Biol 1: 20–36. doi: 10.1093/jmcb/mjp001
![]() |
[164] |
165. Lanzavecchia A (1985) Antigen-specific interaction between T and B cells. Nature 314: 537–539. doi: 10.1038/314537a0
![]() |
[165] |
166. Shumilina E, Huber SM, Lang F (2011) Ca2+ signaling in the regulation of dendritic cell functions. Am J Physiol Cell Ph 300: C1205–C1214. doi: 10.1152/ajpcell.00039.2011
![]() |
[166] |
167. Cowen DS, Lazarus HM, Shurin SB, et al. (1989) Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. J Clin Invest 83: 1651–. doi: 10.1172/JCI114064
![]() |
[167] | 168. Bretou M, Sáez PJ, Sanséau D, et al. (2017) Lysosome signaling controls the migration of dendritic cells. Sci Immunol 2: In press. |
[168] |
169. Vukcevic M, Zorzato F, Spagnoli G, et al. (2010) Frequent calcium oscillations lead to NFAT activation in human immature dendritic cells. J Biol Chem 285: 16003–16011. doi: 10.1074/jbc.M109.066704
![]() |
[169] |
170. Jégouzo SAF, Quintero-Martinez, Ouyang X, et al. (2013) Organization of the extracellular portion of the macrophage galactose receptor: a trimeric cluster of simple binding sites for N-acetylgalactosamine. Glycobiology 23: 853–864. doi: 10.1093/glycob/cwt022
![]() |
[170] | 171. Humeau J, Bravo-San PJ, Vitale I, et al. (2017) Calcium signaling and cell cycle: progression or death. Cell Calcium 17: In press. |
[171] |
172. Nicotera P, Orrenius S (1998) The role of calcium in apoptosis. Cell Calcium 23: 173–180. doi: 10.1016/S0143-4160(98)90116-6
![]() |
[172] | 173. Schwarz EC, Qu B, Hoth M (013) Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killing cells. BBA-Mol Cell Res 1833: 1603–1611. |
[173] |
174. Cui C, Merritt R, Fu L, et al. (2017) Targeting calcium signaling in cancer therapy. Acta Pharm Sinica B 7: 3–17. doi: 10.1016/j.apsb.2016.11.001
![]() |
[174] |
175. Halling DB, Liebeskind BJ, Hall AW, et al. (2016) Conserved properties of individual Ca2+-binding sites in calmodulin. Proc Nat Acad Sci USA 113: E1216–E1225. doi: 10.1073/pnas.1600385113
![]() |
[175] |
176. Agrawal RS, Connolly SF, Herrmann TL, et al. (2007) MHC class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II. J Leukocyte Biol 82: 686–699. doi: 10.1189/jlb.0107045
![]() |
[176] |
177. Connolly SF, Kusner DJ (2007) The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens. Immunol Res 39: 115–127. doi: 10.1007/s12026-007-0076-1
![]() |
[177] |
178. Shi Y (2009) Serine/threonine phosphatases: mechanism through structure. Cell 139: 468–484. doi: 10.1016/j.cell.2009.10.006
![]() |
[178] | 179. Song MS, Salmena L, Pandolfi PP (2012) The functions and regulation of the PTEN tumor suppressor. Nat Rev Mol Cell Bio 13: 283–296. |
[179] |
180. Cho US, Xu W (2007) Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature 445: 53–57. doi: 10.1038/nature05351
![]() |
[180] |
181. Feske S (2007) Calcium signaling in lymphocyte activation and disease. Nat Rev Immunol 7: 690–702. doi: 10.1038/nri2152
![]() |
[181] |
182. Müller MR, Rao A (2010) NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10: 645–656. doi: 10.1038/nri2818
![]() |
[182] |
183. Nakanishi A, Hatano N, Fujiwara Y, et al. (2017) AMP-activated protein-kinase-mediated feedback phosphorylation controls the Ca2+/calmodulin dependence of Ca2+/CaM-dependent protein kinase kinase β. J Biol Chem 292: 19804–19813. doi: 10.1074/jbc.M117.805085
![]() |
[183] |
184. Gaertner TR, Kolodziej SJ, Wang D, et al. (2004) Comparative analysis of the three-dimensional structures and enzymatic properties of α, β, γ, and δ isoforms of Ca2+-calmodulin-dependent protein kinase II. J Biol Chem 279: 12484–12494. doi: 10.1074/jbc.M313597200
![]() |
[184] |
185. Wiede F, Dudakov JA, Lu KH, et al. (2017) PTPN2 regulates T cell lineage commitment and αβ versus γδ specification. J Exp Med 214: 2733–2758. doi: 10.1084/jem.20161903
![]() |
[185] |
186. Wang X, Marks CR, Perfitt TL, et al. (2017) A novel mechanism for Ca2+/calmodulin-dependent protein kinase II targeting to L-type Ca2+ channels that initiates long-range signaling to the nucleus. J Biol Chem 292: 17324–17336. doi: 10.1074/jbc.M117.788331
![]() |
[186] |
187. Lin MY, Zal T, Ch'En IL, et al. (2005) A pivotal role for the multifunctional calcium/calmodulin-dependent protein kinase II in T cells: from activation to unresponsiveness. J Immunol 174: 5583–5592. doi: 10.4049/jimmunol.174.9.5583
![]() |
[187] | 188. Ratner AJ, Bryan R, Weber A, et al. (2017) Cystic fibrosis pathogens activate Ca2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. J Biol Chem 276: 19267–19275. |
[188] | 189. Bononi A, Agnoletto C, De ME, et al. (2011) Protein kinases and phosphatases in the control of cell fate. Enz Res 2011: 329098–329113. |
[189] |
190. Suzuki K, Hata S, Kawabata Y, et al. (2004) Structure, activation, and biology of calpain. Diabetes 53: S12–S18. doi: 10.2337/diabetes.53.2007.S12
![]() |
[190] | 191. Frangioni JV, Oda A, Smith M, et al. (1993) Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J 12: 4843–4856. |
[191] | 192. Baba Y, Kurosaki T (2016) Role of calcium signaling in B cell activation and biology. Curr Top Microbiol 393: 143–147. |
[192] |
193. Vaeth M, Zee I, Concepcion AR, et al. (2015) Ca2+ signaling but not store-operated Ca2+ entry is required for the function of macrophages and dendritic cells. J Immunol 195: 1202–1217. doi: 10.4049/jimmunol.1403013
![]() |
[193] |
194. Ledderose C, Bao Y, Lidicky M, et al. (2014) Mitochondria are gate-keepers of T cell function by producing the ATP that drives purinergic signaling. J Biol Chem 289: 25936–25945. doi: 10.1074/jbc.M114.575308
![]() |
[194] | 195. Zizzari IG, Napoletano C, Battisti F, et al. (2015) MGL receptor and immunity: when the ligand can make the difference. J Immunol Res 2015: 450695–450702. |
[195] |
196. van Vliet SJ, Bay S, Vuist IM, et al. (2013) MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion. J Leukocyte Biol 94: 315–323. doi: 10.1189/jlb.1012520
![]() |
[196] |
197. Nunes P, Demaurex N (2010) The role of calcium signaling in phagocytosis. J Leukocyte Biol 88: 57–68. doi: 10.1189/jlb.0110028
![]() |
[197] |
198. Lm VDB, Gringhuis SI, Geijtenbeek TB (2012) An evolutionary perspective on C-type lectins in infection and immunity. Ann Ny Acad Sci 1253: 149–158. doi: 10.1111/j.1749-6632.2011.06392.x
![]() |
[198] | 199. Kushchayev SV, Sankar T, Eggink LL, et al. (2012) Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part 1: stimulatory effects on blood monocytes and monocyte-derived cells of the brain. Cancer Manag Res 4: 309–323. |
[199] | 200. Kushchayev SV, Sankar T, Eggink LL, et al. (2012) Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survival. Cancer Manag Res 4: 325–334. |
[200] | 201. Roby KF, Eggink LL, Hoober JK (2017) An innovative immunotherapeutic strategy for ovarian cancer: glycomimetic peptides [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017, Washington DC. Available from: http://cancerres.aacrjournals.org/content/77/13_Supplement/170. |
1. | Energy Accounting for a Renewable Energy Future, 2019, 12, 1996-1073, 4280, 10.3390/en12224280 | |
2. | Stephen Jia Wang, Patrick Moriarty, 2018, Chapter 1, 978-3-319-73608-2, 1, 10.1007/978-3-319-73610-5_1 | |
3. | Stephen Jia Wang, Patrick Moriarty, 2018, Chapter 6, 978-3-319-73608-2, 105, 10.1007/978-3-319-73610-5_6 | |
4. | Patrick Moriarty, Damon Honnery, The risk of catastrophic climate change: Future energy implications, 2021, 128, 00163287, 102728, 10.1016/j.futures.2021.102728 | |
5. | Patrick Moriarty, Damon Honnery, Ecosystem maintenance energy and the need for a green EROI, 2019, 131, 03014215, 229, 10.1016/j.enpol.2019.05.006 | |
6. | Patrick Moriarty, Damon Honnery, Feasibility of a 100% Global Renewable Energy System, 2020, 13, 1996-1073, 5543, 10.3390/en13215543 | |
7. | Patrick Moriarty, Damon Honnery, 2019, 9780128141045, 221, 10.1016/B978-0-12-814104-5.00006-5 | |
8. | Patrick Moriarty, Damon Honnery, New Energy Technologies: Microalgae, Photolysis and Airborne Wind Turbines, 2021, 3, 2413-4155, 5, 10.3390/sci3010005 | |
9. | Patrick Moriarty, Xiaoyu Yan, Stephen Jia Wang, Liquid biofuels: not a long-term transport solution, 2019, 158, 18766102, 3265, 10.1016/j.egypro.2019.01.986 | |
10. | Shutaro Takeda, Andrew John Chapman, Hoseok Nam, 2021, Chapter 24, 978-981-15-6774-2, 371, 10.1007/978-981-15-6775-9_24 | |
11. | Patrick Moriarty, Damon Honnery, 2019, 9780128162293, 273, 10.1016/B978-0-12-816229-3.00014-4 | |
12. | Alexandre Babin, Céline Vaneeckhaute, Maria C. Iliuta, Potential and challenges of bioenergy with carbon capture and storage as a carbon-negative energy source: A review, 2021, 146, 09619534, 105968, 10.1016/j.biombioe.2021.105968 | |
13. | Muhammad Faisal, Aamer Saeed, 2021, Chapter 2, 978-3-030-59279-0, 15, 10.1007/978-3-030-59280-6_2 | |
14. | Patrick Moriarty, Damon Honnery, New Energy Technologies: Microalgae, Photolysis and Airborne Wind Turbines, 2019, 1, 2413-4155, 43, 10.3390/sci1020043 | |
15. | Mathilde Fajardy, Niall Mac Dowell, The energy return on investment of BECCS: is BECCS a threat to energy security?, 2018, 11, 1754-5692, 1581, 10.1039/C7EE03610H | |
16. | Patrick Moriarty, Can Bioenergy Once again Become a Major Global Energy Source?, 2022, 2, 2673-8392, 1357, 10.3390/encyclopedia2030091 | |
17. | Philipp Günther, Felix Ekardt, Human Rights and Large-Scale Carbon Dioxide Removal: Potential Limits to BECCS and DACCS Deployment, 2022, 11, 2073-445X, 2153, 10.3390/land11122153 | |
18. | Jian Guo, Minghao Zhong, Shuran Chen, Analysis and simulation of BECCS vertical integration model in China based on evolutionary game and system dynamics, 2022, 252, 03605442, 124000, 10.1016/j.energy.2022.124000 | |
19. | Patrick Moriarty, Damon Honnery, 2022, Chapter 3, 978-981-19-0766-1, 35, 10.1007/978-981-19-0767-8_3 | |
20. | Patrick Moriarty, Damon Honnery, The limits of renewable energy, 2021, 9, 2333-8334, 812, 10.3934/energy.2021037 | |
21. | Maksym Chepeliev, Oleksandr Diachuk, Roman Podolets, Galyna Trypolska, The role of bioenergy in Ukraine's climate mitigation policy by 2050, 2021, 152, 13640321, 111714, 10.1016/j.rser.2021.111714 | |
22. | Jo Smith, Jenny Farmer, Pete Smith, Dali Nayak, The role of soils in provision of energy, 2021, 376, 0962-8436, 20200180, 10.1098/rstb.2020.0180 | |
23. | Zihe Liu, Shuobo Shi, Yuchao Ji, Kai Wang, Tianwei Tan, Jens Nielsen, Opportunities of CO2-based biorefineries for production of fuels and chemicals, 2023, 1, 29501555, 75, 10.1016/j.greenca.2023.09.002 | |
24. | Emmanuel Binyet, Hsin-Wei Hsu, Decarbonization strategies and achieving net-zero by 2050 in Taiwan: A study of independent power grid region, 2024, 204, 00401625, 123439, 10.1016/j.techfore.2024.123439 | |
25. | Patrick Moriarty, Damon Honnery, 2025, 9780443219276, 505, 10.1016/B978-0-443-21927-6.00013-1 |
Food commodity | 2011/131 | 20231 | % increase |
Grains (Mt) | 2391 | 2753 | 15.2 |
Animal feed | 819 | 976 | 19.2 |
Biofuels | 145 | 183 | 25.5 |
Food & other | 1427 | 1594 | 11.7 |
Grain area (Mha) | 716 | 736 | 2.8 |
Yield (t/ha) | 3.34 | 3.74 | 12.0 |
Milk (Mt) | 749 | 928 | 24.0 |
Meat (kg/capita) | 33.8 | 36.2 | 7.1 |
1crop years. Source: [16]. |
Material | kg CO2-eq/kg | kg CO2-eq/m3 |
Sawn softwood | 0.30 | 180 |
Concrete | 0.14 | 325 |
Reinforced concrete | 0.18 | 455 |
Steel (reinforcing) | 1.53 | 12,055 |
Aluminium | 8.57 | 23,140 |
Plastics (PVC) | 4.27 | 5975 |
Source: [32] |
Biomass ultilizationpathway | Atmospheric removal of CO2 | Reduction in CO2 emissions by material substitution | Reduction in CO2 emissions by fuel substitution | EROEI |
Burial | X | Negative | ||
Bioenergy (inc. biofuels) | X | Low to medium | ||
Material + burial | X | X | Low | |
Material + bioenergy | X | X | Medium | |
Material + bioenergy + CCS | X | X | X | Low to medium |
Food commodity | 2011/131 | 20231 | % increase |
Grains (Mt) | 2391 | 2753 | 15.2 |
Animal feed | 819 | 976 | 19.2 |
Biofuels | 145 | 183 | 25.5 |
Food & other | 1427 | 1594 | 11.7 |
Grain area (Mha) | 716 | 736 | 2.8 |
Yield (t/ha) | 3.34 | 3.74 | 12.0 |
Milk (Mt) | 749 | 928 | 24.0 |
Meat (kg/capita) | 33.8 | 36.2 | 7.1 |
1crop years. Source: [16]. |
Year | 1990 | 2000 | 2014 |
Wood (non-fuel uses) | 1700 | 1620 | 1836 |
Kiln-fired bricks | NA | NA | 5250a |
Cement | 1227 | 1590 | 4180 |
Steel | 770 | 849 | 1670 |
Plastics | 106 | 160 | 311 |
Aluminium | 20 | 25 | 49 |
a: 2013 figure, and assumes 3.5 kg per brick. Sources [30,33,34,35,36,37] |
Material | kg CO2-eq/kg | kg CO2-eq/m3 |
Sawn softwood | 0.30 | 180 |
Concrete | 0.14 | 325 |
Reinforced concrete | 0.18 | 455 |
Steel (reinforcing) | 1.53 | 12,055 |
Aluminium | 8.57 | 23,140 |
Plastics (PVC) | 4.27 | 5975 |
Source: [32] |
Biomass ultilizationpathway | Atmospheric removal of CO2 | Reduction in CO2 emissions by material substitution | Reduction in CO2 emissions by fuel substitution | EROEI |
Burial | X | Negative | ||
Bioenergy (inc. biofuels) | X | Low to medium | ||
Material + burial | X | X | Low | |
Material + bioenergy | X | X | Medium | |
Material + bioenergy + CCS | X | X | X | Low to medium |